Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Prostatic Neoplasms 2Neoplasms 2Weight Loss 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Lung Neoplasms 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 99Fluorouracil 90Capecitabine 86Radiotherapy 81Dexamethasone 81Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Drug Therapy 65Leucovorin 64Cetuximab 60Erlotinib Hydrochloride 56atezolizumab 53Sorafenib 53Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms × Diet, Fat-Restricted × Clear all
NCT00924937 2021-06-03

CORDIOPREV

Hospital Universitario Reina Sofia de Cordoba

Phase NA Completed
1,002 enrolled

Angina, Unstable, Diabetes Mellitus, Myocardial Infarction, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

NCT02744079 2020-08-31

KetoBreast

Albert Einstein College of Medicine

Phase NA Completed
11 enrolled
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡